Ottawa Hospital-General Campus

Ottawa K1H 8L6

1 studies enrolling now · 4 studies all time

What they study most

Cancer, Carcinoma, Transitional Cell, PD-L1 Negative, PD-L1 Positive, Triple Negative Breast Cancer

Studies at this site

• Met Non Small Cell Cancer Registry (MOMENT) — Recruiting now
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed